This approval paves the way for exports to the world's fourth most populous country. SK bioscience aims to continue to grow as a global vaccine brand beyond Korea by leveraging the advantages of cell-cultured vaccines. SEONGNAM, South Korea, Oct. 23, 2024 /PRNewswire/ -- SK bioscience, a...
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
Seaking AlphaSeeking Alpha / Seaking Alpha 13 hours ago 1 Views
Comments